Your asthma reliever inhaler: never leave home without it.
نویسندگان
چکیده
Received 17 September 2012 Accepted 21 September 2012 CHEST CLINIC Case based discussion JP: A 25-year-old gentleman with asthma attended for routine out-patient review. As part of this consultation, his current symptoms and recent inhaler use were discussed, including whether he ever left home without his reliever inhaler. Though his asthma was well controlled, he reported that he always carried his reliever inhaler with him for use as a bottle opener for the treatment of acute beverage thirst attacks. MP: Asthma patients traditionally use reliever inhalers for symptoms of chest tightness, wheeze and cough, and are generally advised to always keep these inhalers with them at all times. Increasing use of short-acting β-agonists for symptom relief is associated with risk of exacerbation and hospital admission for asthma, and is an important marker of asthma control. There are, however, alternative uses for inhalers that are not immediately apparent to healthcare professionals. These include use to perform ‘frosties’, whereby the inhaler is placed close to the skin and actuated repeatedly. One such alternative use is as a bottle opener for the treatment of an acute beverage thirst attack. This ailment is characterised by irresistible, and often unpredictable, episodes of thirst, in the context of a busy social life. Further information from the patient is required and a diagnostic procedure is suggested. JP: The patient was asked to simulate an acute beverage thirst attack and demonstrate his reliever inhaler technique. In keeping with recommendations, 7 this was performed with full video monitoring. He was presented with glass bottles with non-twistable metal bottle caps. Four demonstrations were performed using one inhaler and four beverage bottles. A total of 4/4 (100%) attempts were successful, leading to immediate relief of the beverage thirst attack (figure 1 and online Video supplement). Mean time to successful opening (SD) was 3 (1) s and within-patient repeatability was 100%. Mean bottle-top ejection height (SD) was 1 (0.7) m, with some collateral loss of fluid in the process. MP: This is the first reported case of the use of an asthma reliever inhaler to alleviate the symptoms of an acute beverage thirst attack. While traditionally used for the relief of asthma symptoms, an asthma inhaler can be indispensible in the relief of acute thirst in the context of bottle opener absence. This case provides a timely reminder regarding the importance of carrying a reliever inhaler at all times.
منابع مشابه
Effectiveness of Same Versus Mixed Asthma Inhaler Devices: A Retrospective Observational Study in Primary Care
PURPOSE Correct use of inhaler devices is fundamental to effective asthma management but represents an important challenge for patients. The correct inhalation manoeuvre differs markedly for different inhaler types. The objective of this study was to compare outcomes for patients prescribed the same inhaler device versus mixed device types for asthma controller and reliever therapy. METHODS T...
متن کاملAsthma treatment preference study: a conjoint analysis of preferred drug treatments.
OBJECTIVE Assessment of patient preferences for attributes of asthma treatments. METHODS Two hundred ninety-eight patients (age range, 18 to 60 years) from 15 centers in Sweden completed a questionnaire concerning their asthma, and ranked 18 alternative treatments using conjoint analysis. Patients were receiving treatment with either inhaled corticosteroids (ICS) and short-acting bronchodilat...
متن کاملA smarter way to manage asthma with a combination of a long-acting β2-agonist and inhaled corticosteroid
Symbicort SMART(R) (Symbicort Maintenance and Reliever Therapy) represents a new and unique way of treating patients with moderate-to-severe asthma, ie, those patients who require combination treatment with an inhaled corticosteroid and a long-acting inhaled beta(2)-agonist. Symbicort SMART enables patients to use only one inhaler, the budesonide-formoterol combination inhaler, for both mainten...
متن کاملCorticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis
BACKGROUND Current guidelines recommend a single inhaler maintenance and reliever therapy (SMART) regimen for moderate to severe asthma. However, evidence for the inhaled corticosteroid plus fast-onset-acting β2-agonist (ICS/FABA) as reliever therapy in management of intermittent and mild asthma patients is lacking. OBJECTIVE To systematically explore efficacy and safety of the proof-of-conce...
متن کاملCost-effectiveness of formoterol and salbutamol as asthma reliever medication in Sweden and in Spain.
This study aimed to evaluate the cost-effectiveness of formoterol (Oxis) Turbuhaler 4.5 microg and salbutamol 200 microg as reliever medications in Sweden and Spain. The study used data on effectiveness (exacerbations and symptom-free days) and resource utilisation from an open, 6-month, parallel-group, multicentre randomised trial with 18,124 asthma patients in 24 countries. Country-specific u...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Thorax
دوره 67 12 شماره
صفحات -
تاریخ انتشار 2012